ОРГАНОЗБЕРІГАЛЬНІ ОПЕРАЦІЇ З ПРИВОДУ РАКУ МОЛОЧНОЇ ЗАЛОЗИ

Автор(и)

  • R. V. Seniutovych
  • O. I. Ivashchuk
  • V. Yu. Bodiaka
  • O. H. Ushenko
  • L. Ya. Kushneryk
  • I. D. Postevka

DOI:

https://doi.org/10.24061/1727-0847.15.2.2016.54

Ключові слова:

рак, молочна залоза, органозберігальні операції, хірургічні краї

Анотація

Представлений огляд літератури з проблем оцінки адекватності хірургічних країв за умов органозберігальних операцій з приводу раку молочної залози. Дозволені хірургічні краї шириною 1,0-2,0 мм при забарвленні поверхні препаратом. Одностайної думки щодо показань до проведення реексцизій немає.

Посилання

Azu M, Abrahamse P, Katz SJ. What is an adequate margin for breast-conserving surgery? Surgeon Attitudes and Correlates. Ann. Surg. Oncol. 2010;17:558-563.

Blair SL, Thompson K, Rococco J. Attaining negative margins in breast conservation operations: Is there a consensus among breast surgeons? J. Am. Coll. Surg. 2009;209:608-613.

McCahill LE, Single RM, Aiello EJ. Bowles Variability in reexcision following breast conservation surgery. JAMA. 2012;307:467-475.

Schwartz GF, Veronesi U, Clough KB. Proceedings of the consensus conference on breast conservation. Cancer. 2006;107:365-373.

Houssami N, Macaskill P, Marinovich ML. Metaanalysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast conserving surgery. Eur. J. Cancer. 2010;6:3219-3232.

Dunne C, Burke JP, Morrow M. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J. Clin. Oncol. 2009;27:1615-1620.

Morrow M, Katz SJ. The challenge of developing quality measures for breast cancer surgery. JAMA. 2012;307:509-510.

Wapnir IL, Dignam JJ, Fisher B. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J. Natl. Cancer Inst. 2011;103:478-488.

Atkins J, Al Mushawah F, Appleton CM. Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors. J. Surg. Res. 2012;177:109-115.

McGhan LJ, McKeever SC, Pockaj BA. Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution. Ann. Surg. Oncol. 2011;18:3096-3101.

Jeevan R, Cromwell DA, Trivella M. Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ. 2012;345:4505.

Tot T. The role of large format histopathology in assessing subgross morphological prognostic parameters: a single institution report of 1000 consecutive breast cancer cases. Int. J. Breast. Cancer. 2012;2012:395-415.

Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am. J. Surg. 2002;184:383-393.

Taghian A, Mohiuddin M, Jagsi R. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann. Surg. 2005;241:629-639.

Caruso F, Ferrara M, Castiglione G. Therapeutic mammaplasties: full local control of breast cancer in one surgical stage with frozen section. Eur. J. Surg. Oncol. 2011;37:871-875.

Guidroz JA, Larrieux G, Liao J. Sampling of secondary margins decreases the need for re-excision after partial mastectomy. Surg. 2011;150:802-809.

Chakravorty A, Shrestha AK, Sanmugalingam N. How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery. Eur. J. Surg. Oncol. 2012;38:395-398.

Persing S, James TA, Mace J. Variability in the quality of pathology reporting of margin status following breast cancer surgery. Ann. Surg. Oncol. 2011;18:3061-3065.

Arentz C, Baxter K, Boneti C. Ten-year experience with hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann. Surg. Oncol. 2010;17(suppl 3):378-383.

Margenthaler JA, Gao F, Klimberg VS. Margin index: a new method for prediction of residual disease after breast-conserving surgery. Ann. Surg. Oncol. 2010;17:2696-2701.

Fisher B, Anderson S, Bryant J. Twenty year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. 2002;347:1233-1241.

Halasz LM, Sreedhara M, Chen YH. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ. Int. J. Radiat. Oncol. Biol. Phys. 2012;82:581-586.

Mamounas EP, Tang G, Fisher B. Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20. J. Clin. Oncol. 2010;28:1677-1683.

Dignam JJ, Dukicv VM, Anderson SJ. Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer. Breast Cancer Res. Treat. 2009;116:595-602.

Del Turco MR, Ponti A, Bick U. Quality indicators in breast cancer care. Eur. J. Cancer. 2010;46:2344-2356.

Aiello Bowles EJ, Feigelson HS, Barney T. Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database. BMC Cancer. 2012;12:136.

Mook J, Klein R, Kobbermann A. Volume of excision and cosmesis with routine cavity shave margins technique. Ann. Surg. Oncol. 2012;19:886-891.

Smith TJ, Landercasper J, Gundrum JD. Perioperative quality metrics for one step breast cancer surgery: a patient-centered approach. J. Surg. Oncol. 2010;102:34-38.

##submission.downloads##

Опубліковано

2016-04-26

Номер

Розділ

Наукові огляди